Newron Pharmaceuticals S.p.A. (FRA:NP5)
8.66
-0.04 (-0.46%)
Last updated: May 13, 2025
Newron Pharmaceuticals Market Cap
Newron Pharmaceuticals has a market cap or net worth of €174.79 million as of May 13, 2025. Its market cap has increased by 30.89% in one year.
Market Cap
174.79M
Enterprise Value
215.51M
Revenue
51.39M
Ranking
n/a
PE Ratio
11.03
Stock Price
€8.66
Market Cap Chart
Since December 12, 2006, Newron Pharmaceuticals's market cap has decreased from 194.15M to 174.79M, a decrease of -9.97%. That is a compound annual growth rate of -0.57%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 306.23B |
Siemens Aktiengesellschaft | 173.26B |
Deutsche Telekom AG | 154.94B |
Allianz SE | 135.31B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 75.88B |
Rheinmetall AG | 72.55B |
Siemens Energy AG | 59.75B |
Siemens Healthineers AG | 54.46B |